Kényszerű város Tökéletes ge marker vaccine ültetvényes Levelek gyűjtése pép
Frontiers | Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
Technical Bulletin
Understanding which IBR vaccine to use in your herd
Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle
Immuno | Free Full-Text | Rescuing Immunosenescence via Non-Specific Vaccination
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - ScienceDirect
Development of an inactivated vaccine candidate for SARS-CoV-2 | Science
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis: Trends in Molecular Medicine
The how's and what's of vaccine reactogenicity | npj Vaccines
Prospects for a safe COVID-19 vaccine | Science Translational Medicine
New strategies for Leptospira vaccine development based on LPS removal | PLOS ONE
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients - ScienceDirect
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses | Nature
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
BHV-1: New Molecular Approaches to Control a Common and Widespread Infection | Molecular Medicine | Full Text
Vaccines | Free Full-Text | Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR